City

Baltimore (2)

Bronx (1)

Los Angeles (1)

New York (1)

Saint Louis (1)

Overall Status

Completed (1)

Terminated (1)

Phase

early phase 1 (1)

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

cyclophosphamide (1)

filgrastim (1)

ibrutinib (1)

laboratory biomarker analysis (1)

peripheral blood stem cell transplantation (1)

pharmacological study (1)

rituximab (1)

yttrium y 90 ibritumomab tiuxetan (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

procedure (1)

radiation (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

recurrent mantle cell lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adult B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Cutaneous B-Cell Non-Hodgkin Lymphoma Trial in United States

Terminated

Adult B Acute Lymphoblastic Leukemia
+28 more

Ibrutinib
+2 more

Los Angeles, California
+6 more

Aug 18, 2015

Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous

Completed

Contiguous Stage II Adult Diffuse Large Cell Lymphoma
+49 more

rituximab
+4 more

Baltimore, Maryland

Johns Hopkins University

Jan 8, 2013